Stephanie Azali

Title: The Innovative Contributions of Stephanie Azali

Introduction

Stephanie Azali is a prominent inventor based in Woodland Hills, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid-state forms of various compounds. With a total of six patents to her name, her work has had a substantial impact on drug formulation and delivery.

Latest Patents

Among her latest patents, Azali has developed crystalline and amorphous forms of a complex compound, specifically 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(2-propanyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl)pyrido[2,3-d]pyrimidin-2(1H)-one. This includes several anhydrous, hydrate, and solvate forms, as well as pharmaceutical compositions and methods for treating diseases mediated by KRAS G12C inhibition. Her innovative approaches in solid-state chemistry are paving the way for new therapeutic options.

Career Highlights

Stephanie Azali has worked with leading companies in the pharmaceutical industry, including Amgen Inc. and Cytokinetics, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Throughout her career, Azali has collaborated with notable colleagues such as Mary Chaves and Ron C. Kelly. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Stephanie Azali's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of new treatments and solid-state formulations.